405 related articles for article (PubMed ID: 27871444)
1. Polyneuropathy in levodopa-treated Parkinson's patients.
Szadejko K; Dziewiatowski K; Szabat K; Robowski P; Schinwelski M; Sitek E; Sławek J
J Neurol Sci; 2016 Dec; 371():36-41. PubMed ID: 27871444
[TBL] [Abstract][Full Text] [Related]
2. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
[TBL] [Abstract][Full Text] [Related]
3. Correlations Between Methionine Cycle Metabolism, COMT Genotype, and Polyneuropathy in L-Dopa Treated Parkinson's Disease: A Preliminary Cross-Sectional Study.
Andréasson M; Brodin L; Laffita-Mesa JM; Svenningsson P
J Parkinsons Dis; 2017; 7(4):619-628. PubMed ID: 28759974
[TBL] [Abstract][Full Text] [Related]
4. When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson's disease?
De Luka SR; Svetel M; Pekmezović T; Milovanović B; Kostić VS
Vojnosanit Pregl; 2014 Apr; 71(4):346-51. PubMed ID: 24783414
[TBL] [Abstract][Full Text] [Related]
5. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
Ceravolo R; Cossu G; Bandettini di Poggio M; Santoro L; Barone P; Zibetti M; Frosini D; Nicoletti V; Manganelli F; Iodice R; Picillo M; Merola A; Lopiano L; Paribello A; Manca D; Melis M; Marchese R; Borelli P; Mereu A; Contu P; Abbruzzese G; Bonuccelli U
Mov Disord; 2013 Sep; 28(10):1391-7. PubMed ID: 23836370
[TBL] [Abstract][Full Text] [Related]
6. Polyneuropathy associated with duodenal infusion of levodopa in Parkinson's disease: features, pathogenesis and management.
Uncini A; Eleopra R; Onofrj M
J Neurol Neurosurg Psychiatry; 2015 May; 86(5):490-5. PubMed ID: 25168395
[TBL] [Abstract][Full Text] [Related]
7. Serum homocysteine and physical exercise in patients with Parkinson's disease.
Nascimento CM; Stella F; Garlipp CR; Santos RF; Gobbi S; Gobbi LT
Psychogeriatrics; 2011 Jun; 11(2):105-12. PubMed ID: 21707858
[TBL] [Abstract][Full Text] [Related]
8. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
9. Increased Prevalence of Polyneuropathy in Parkinson's Disease Patients: An Observational Study.
Conradt C; Guo D; Miclea A; Nisslein T; Ismail C; Chatamra K; Andersohn F
J Parkinsons Dis; 2018; 8(1):141-144. PubMed ID: 29154292
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of SUDOSCAN in predicting autonomic neuropathy in patients with Parkinson's disease.
Xu X; Liao J; Dong Q; Qin F; Li J; Sun X; Lu T; Fang L; Peng F; Lu Z; Qiu W
Parkinsonism Relat Disord; 2019 Jul; 64():60-65. PubMed ID: 30890381
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients.
Ando R; Iwaki H; Tsujii T; Nagai M; Nishikawa N; Yabe H; Aiba I; Hasegawa K; Tsuboi Y; Aoki M; Nakashima K; Nomoto M;
Intern Med; 2018 Jul; 57(14):1977-1982. PubMed ID: 29491315
[TBL] [Abstract][Full Text] [Related]
12. Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson's disease.
Park JS; Park D; Ko PW; Kang K; Lee HW
Neurol Sci; 2017 Oct; 38(10):1799-1804. PubMed ID: 28726051
[TBL] [Abstract][Full Text] [Related]
13. The influence of levodopa, entacapone and homocysteine on prevalence of polyneuropathy in patients with Parkinson's disease.
Grofik M; Sivák Š; Nosáľ V; Turčanová Koprušáková M; Michalik J; Čierny D; Tatarková Z; Kurča E
J Neurol Sci; 2018 Sep; 392():28-31. PubMed ID: 30097148
[No Abstract] [Full Text] [Related]
14. Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens.
Mancini F; Comi C; Oggioni GD; Pacchetti C; Calandrella D; Coletti Moja M; Riboldazzi G; Tunesi S; Dal Fante M; Manfredi L; Lacerenza M; Cantello R; Antonini A
Parkinsonism Relat Disord; 2014 Jan; 20(1):27-31. PubMed ID: 24099722
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
Ozekmekçi S; Apaydin H; Kiliç E
Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
[TBL] [Abstract][Full Text] [Related]
16. Small fiber neuropathy in Parkinson's disease: A clinical, pathological and corneal confocal microscopy study.
Kass-Iliyya L; Javed S; Gosal D; Kobylecki C; Marshall A; Petropoulos IN; Ponirakis G; Tavakoli M; Ferdousi M; Chaudhuri KR; Jeziorska M; Malik RA; Silverdale MA
Parkinsonism Relat Disord; 2015 Dec; 21(12):1454-60. PubMed ID: 26578039
[TBL] [Abstract][Full Text] [Related]
17. Effects of levodopa on retina in Parkinson disease.
Sen A; Tugcu B; Coskun C; Ekinci C; Nacaroglu SA
Eur J Ophthalmol; 2014; 24(1):114-9. PubMed ID: 23828323
[TBL] [Abstract][Full Text] [Related]
18. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
Cova I; Di Battista ME; Vanacore N; Papi CP; Alampi G; Rubino A; Valente M; Meco G; Contri P; Di Pucchio A; Lacorte E; Priori A; Mariani C; Pomati S
Parkinsonism Relat Disord; 2017 Jan; 34():38-42. PubMed ID: 28029554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
